Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...

Pharmaceutical Intermediates are a class of chemical compounds used as key components in the manufacturing of drugs, bridging the gap between raw materials and the final formulation of medicines. They ...

The pharmaceutical intermediates market, by distribution channel, is segmented into distributor, and direct sales. The direct sales segment held the largest share of the market in 2020, and ...

Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...

[296 Pages Report] The rapidly increasing prevalence of chronic diseases around the world is expected to fuel the need for novel drugs and better treatment option would further drive the growth of the ...

Global private equity (PE) investors are in a rush to bet on Indian firms that are in the thriving business of manufacturing active pharmaceutical ingredients (API), vaccine-related manufacturing, and ...

Strong growth is projected for the pharmaceutical industry in China, offering opportunities for drug companies and manufacturers of active pharmaceutical ingredients. The global pharmaceutical market ...

Anlon Healthcare Limited is a Gujarat based pharmaceutical API and intermediates manufacturer with a growing manufacturing presence. While the industry faces heavy competition from Chinese players, ...

Report Ocean has released a new report on the API Intermediate market, offering a comprehensive analysis of various factors, including market restraints, drivers, and opportunities. The report ...

The custom manufacturer Lonza Group (Basel, Switzerland) will invest $200 million in Nansha Guangzhou, China, for production of active pharmaceutical ingredients (APIs) and intermediates. The custom ...